| Literature DB >> 32414043 |
Arnaud Bianchi1, Émilie Velot1,2, Hervé Kempf1, Kamil Elkhoury3, Laura Sanchez-Gonzalez3, Michel Linder3, Cyril Kahn3, Elmira Arab-Tehrany3.
Abstract
Investigations in cartilage biology have been hampered by the limited capacity of chondrocytes, especially inEntities:
Keywords: PUFA; chondrocyte; drug delivery system; joint regenerative medicine; liposomes
Mesh:
Substances:
Year: 2020 PMID: 32414043 PMCID: PMC7279141 DOI: 10.3390/ijms21103436
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Physical evaluation of nanoliposomes. (A) Schematic representation of a nanoliposome; (B) transmission electron microscopic images of nanoliposomes; (C) nanoliposomes size distribution obtained from NTA (100–400 nm); (D) particle hydrodynamic diameter obtained from Nanoparticle Tracking Analysis (NTA) software.
Figure 2Impact of nanoliposomes on chondrocytes viability. Rat chondrocytes were exposed to increasing concentrations of nanoliposomes (20, 50, 100, 500, and 1000 µg/mL) for 3, 5, and 7 days. Metabolic activity was assessed using the 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The cell metabolic activity results on the different membranes are presented in % versus control results (as 100%). The results shown are mean ± SD of at least four individual experiments. * p < 0.01 and ** p < 0.001 compared to control for each time point.
Figure 3Lactate dehydrogenase activity of chondrocytes in contact with nanoliposomes. Rat chondrocytes were exposed to increasing concentrations of nanoliposomes (20, 50, 100, 500, and 1000 µg/mL) for 3, 5, and 7 days. (A) Lactate dehydrogenase (LDH) release was determined as described in Section 3; (B) DNA concentrations were measured to estimate cell proliferation. The results shown are mean ± SD of at least four individual experiments. * p < 0.01 and ** p < 0.001 compared to control for each time point.
Figure 4Representative pictures showing the effect of nanoliposome exposure on chondrocytes death. Rat chondrocytes were exposed to increasing concentrations of nanoliposomes (20, 50, 100, 500, and 1000 µg/mL) for 7 days. Live/Dead Cellular Viability/Cytotoxicity Kit from Sigma was used to differentiate live from dead cells. The experiment was performed four times with three biological replicates for each condition tested. Live cells are stained in green and dead cells in red. Immunofluorescence labeling was detected using fluorescence microscopy (DMI 3000B, Leica, Wetzlar, Germany) at 40×, exposure time was between 1 and 5 s. Scale bars on images represents 50 μm.
Figure 5Effect of nanoliposomes exposition on the expression of chondrocytes specific markers. Rat chondrocytes were exposed to increasing concentrations of nanoliposomes (20, 50, 100, and 500 µg/mL) for 24 h or with 10 ng/mL rhIL-1β (A–C) or 100 ng/mL rhFGF23 (D, E). Total RNA was extracted then reverse transcribed into cDNA and analyzed by RT-PCR. The relative abundance of type II collagen (A), Sox-9 (B), aggrecan (C), type X collagen (D), and MMP13 (E) mRNAs were normalized to RP29 mRNA. The comparison was made by using the ΔΔCt method with the fold value of reference = 1. The results shown are mean ± SD of at least four individual experiments. * p < 0.01 and ** p < 0.001 compared to control for each time point.
Sequences of specific primers for RT-PCR analyses.
| Genes | Sequences 5′-3′ |
|---|---|
| ACAN | Fw: CAA-CCT-CCT-GGG-TGT-AAG-GA |
| Rev: TGT-AGC-AGA-TGG-CGT-CGT-AG | |
| Sox-9 | Fw: CTG-AAG-AAG-GAG-AGC-GAG-GA |
| Rev: GGT-CCA-GTC-ATA-GCC-CTT-CA | |
| Col II | Fw: TCC-CTC-TGG-TTC-TGA-TGG-TC |
| Rev: CTC-TGT-CTC-CAG-ATG-CAC-CA | |
| Col X | Fw: ATA-TCC-TGG-GGA-TCC-AGG-TC |
| Rev: TGG-GTC-ACC-CTT-AGA-TCC-AG | |
| MMP13 | Fw: CTT-CTG-GCA-CAC-GCT-TTT-CC |
| Rev: AGC-TGC-TTG-TCC-AGG-TTT-CA | |
| RP29 | Fw: CTC-TAA-CCG-CCA-CGG-TCT-GA |
| Rev: ACT-AGC-ATG-ATT-GGT-ATC-AC |
ACAN: aggrecan; Sox-9: SRY (Sex-Determining Region Y)-Box 9; Col II: type II collagen; Col X: type X collagen; MMP: metalloproteinase; RP: ribosomal protein.